Home NDC 50881-007-07 OPZELURA
Product NDC 50881-007
Requested package NDC 50881-007-07
11-digit product format 508810007
Labeler code 50881
Product ID 50881-007_a32bcaac-6cd8-41be-8686-3e10268e0539
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ruxolitinib
Dosage form CREAM
Route TOPICAL
Labeler Incyte Corporation
Application NDA215309
Marketing category NDA
Marketing start 2021-09-21
Substance RUXOLITINIB PHOSPHATE
Active strength 15 mg/g
Pharmacologic classes Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215309-001 OPZELURA RUXOLITINIB PHOSPHATE EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21
Orange Book patents# Current patent rows page 1 of 1 · 39 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215309-001 I-896 2025-07-18 N215309-001 PED 2026-01-18 N215309-001 NPP 2028-09-18
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215309-001 OPZELURA EQ 1.5% BASE CREAM / TOPICAL RLD, RS 2021-09-21 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 24 · 933 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215309-001 10639310 2026-12-12 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9079912 2026-12-12 U-3404 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9079912 2026-12-12 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9974790 2026-12-12 U-3404 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9974790 2026-12-12 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10639310*PED 2027-06-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9079912*PED 2027-06-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 9974790*PED 2027-06-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 7598257 2027-12-24 Drug substance, Drug product 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8415362 2027-12-24 Drug substance, Drug product 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10610530 2028-06-12 U-3404 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10610530 2028-06-12 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8722693 2028-06-12 Drug substance, Drug product 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8822481 2028-06-12 U-3404 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8822481 2028-06-12 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 7598257*PED 2028-06-24 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8415362*PED 2028-06-24 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10610530*PED 2028-12-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8722693*PED 2028-12-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 8822481*PED 2028-12-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10758543 2031-05-20 Drug product 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10869870 2031-05-20 U-3404 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10869870 2031-05-20 U-3229 2021-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11219624 2031-05-20 U-3229 Drug product 2022-02-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11571425 2031-05-20 Drug product 2023-02-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11590136 2031-05-20 U-3229 2023-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11590136 2031-05-20 U-3404 2023-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 12226419 2031-05-20 Drug product 2025-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10758543*PED 2031-11-20 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 10869870*PED 2031-11-20 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11219624*PED 2031-11-20 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11590138 2040-06-10 U-3551 2023-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 12233067 2040-07-28 U-4151 2025-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11510923 2040-09-04 U-3505 2022-12-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11590137 2040-09-04 U-3505 2023-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215309-001 11602536 2041-05-05 U-3550 2023-03-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215309-001 10639310 2026-12-12 U-3229 2021-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215309-001 9079912 2026-12-12 U-3404 2021-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215309-001 9079912 2026-12-12 U-3229 2021-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215309-001 9974790 2026-12-12 U-3404 2021-10-20 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 107 observed states.
Additional Listing Data#
Finished product Yes
Brand name base OPZELURA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RUXOLITINIB PHOSPHATE 15 mg/g
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 436LRU32H5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2570752 Internal RxNorm lookup 2570757 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50881-007 OPZELURA (RUXOLITINIB) CREAM [INCYTE CORPORATION] 11 Current NDC, Legacy NDC, 8 package rows 20240831_24da5509-6631-4795-9d42-273faecd08e7.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50881-007-07 50881000707 1 TUBE in 1 CARTON (50881-007-07) / 100 g in 1 TUBE 1 tube 2022-04-15 0000-00-00 No No Current